WHAT'S THIS?

Home About us Email sign up Basics Features Commentary - General - Best practice - Clinical trial registries - Selective publication - Industry payments - Authorship - Open Access Viewpoints Advertorials Press releases Resources Events Directory Webcasts Freelance Spotlight

Join The Publication Plan LinkedIn Group here. Follow #pubplan. Share |

This is a freely accessible online resource for everyone involved in publication planning. Help us build the site into a valuable resource for, amongst others, medical writers and communications professionals, pharmaceutical industry managers, medical journal editors and publishers. If you have any contributions, ideas, comments about the service or questions about advertising and sponsorship, please contact the Publisher, Peter Llewellyn.

Managed by NetworkPharma

Related Sites

COMMENTARY

This section collates links to previously published articles and news stories. The five latest additions are highlighted below, the rest can be found via the menu on the left.

Access to data in industry-sponsored trials Published 10 December 2011 This article by Andreas Lundh and colleagues in The Lancet, highlights the confusion over what is meant by "full access to data" and concludes that we should work towards a situation in which anonymised raw data are made freely available to the public. Saying "Our patients deserve nothing less than this, which would be highly beneficial for health care." [Link to original source material]

Ghosts in the machine Published 6 December 2011 Ghostwriting in medical publishing on behalf of big drug companies has a long history, finds Rachel Hendrick in this BMJ article, and oversight of the practice has its problems. [Link to original source material]

Publication of clinical trial data: enough of the excuses! Published 29 November 2011 How much negative data goes unpublished? Ryan Woodrow set to find out and his surprising results are detailed here in an article in pharmaphorum. [Link to original source material]

Effect of using reporting guidelines during peer review on quality of final manuscripts submitted to a biomedical journal: masked randomised trial Published 22 November 2011 E Cobo and colleagues conclude in their BMJ article that additional reviews based on reporting guidelines improve manuscript quality, although the observed effect was smaller than hypothesised and not definitively demonstrated.. [Link to original source material]

Ghostwriting: myths and realities - part 2 Published 8 November 2011 Adam Jacobs continues with his myth-busting article in pharmaphorum and says "the fact is that we simply don't know how many papers are ghostwritten". [Link to original source material]

WHAT ELSE?

This web site and associated activities are being managed by NetworkPharma Ltd, Magdalen Centre, The Oxford Science Park, Oxford, OX4 4GA, UK
Telephone +44 (0) 1865 784390 Email: support@networkpharma.com

Related services
[www.EuropeanCMEforum.eu] [www.gCMEp.eu]
[www.KeywordPharma.com] [www.MedCommsForum.com] [www.MedCommsNetworking.co.uk]
[www.MedCommsWorkBook.com] [www.NetworkPharma.tv] [www.NextMedCommsJob.com]